HepatiCan Limited
Making a transformative and disruptive change to the care of patients with acute/severe liver failure.
HepatiCan Limited
Making a transformative and disruptive change to the care of patients with acute/severe liver failure.
HepatiCan device
The biocartridge is cryo-preservable and single use and the biomass is available from frozen in less than a day. With the device already at a clinical scale of 70 billion cells as organoids, it holds 3 patent families and a manufacturing know how, and has an Orphan Drug Designation (ODD) in EMA and FDA jurisdictions.
The HepatiCan device interfaces with an existing standard of care equipment and works as an out-of-body healthy liver, allowing for a patient’s recovery before/instead of liver transplantation and any patient-facing items are designed as disposables.